PRESS RELEASE published on 05/03/2023 at 13:00, 3 years 3 months ago EVNi Clean Nickel(TM) R&D - Preliminary Results Confirm Bioleaching Potential for the W4 Nickel Sulphides
PRESS RELEASE published on 05/02/2023 at 21:50, 3 years 3 months ago EQS-Adhoc: APONTIS PHARMA AG adjusts forecast for fiscal year 2023
PRESS RELEASE published on 04/27/2023 at 07:30, 3 years 3 months ago APONTIS PHARMA with first in-licensing of a Single Pill with two active ingredients for the primary prophylaxis of cardiovascular events - market launch already planned for early 2024
PRESS RELEASE published on 04/20/2023 at 13:00, 3 years 4 months ago EVNi Clean Nickel(TM) R&D - Preliminary Results Confirm Carbon Capture and Storage ("CCS") Potential of the CarLang Area
PRESS RELEASE published on 04/12/2023 at 13:00, 3 years 4 months ago EV Nickel Announces Filing of NI 43-101 Technical Report for Previously Announced CarLang Project Maiden Resource
PRESS RELEASE published on 04/12/2023 at 07:30, 3 years 4 months ago APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential
PRESS RELEASE published on 03/28/2023 at 13:00, 3 years 4 months ago EV Nickel Continues to Expand the High-Grade W4 Zone with Impressive Nickel Drill Hole Intercepts Including 13.1m Grading 1.47% Ni and 2.1m Grading 3.01% Ni
PRESS RELEASE published on 03/09/2023 at 07:30, 3 years 5 months ago APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary calculations
PRESS RELEASE published on 03/06/2023 at 15:05, 3 years 5 months ago EV Nickel Welcomes Ontario Government Investment in its Clean Nickel (TM) Strategy
PRESS RELEASE published on 03/02/2023 at 13:30, 3 years 5 months ago EV Nickel to Present at Multiple Events and Awaits Developments on Clean Nickel (TM), plus Assay Results
Published on 08/26/2026 at 15:25, 37 minutes ago CF Energy Announces Financial Results for the Three-Month and Six-Month Periods Ended June 30, 2026
Published on 08/26/2026 at 15:00, 1 hour 2 minutes ago Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 08/26/2026 at 15:00, 1 hour 2 minutes ago Arcus Announces Voting Results of the Annual General and Special Meeting
Published on 08/26/2026 at 14:30, 1 hour 32 minutes ago Klondike Gold Reports Additional Montana Creek Royalty Gold Receipts, Announces Phase 2 2026 Drill Program and Provides Exploration Update
Published on 08/26/2026 at 14:30, 1 hour 32 minutes ago NV Gold Announces Commencement of 2026 Drill Program at its Slumber Gold Project
Published on 08/26/2026 at 15:10, 52 minutes ago Gastech 2026 Brings Global Energy Leaders to Bangkok as Asia Drives the Next Wave of Demand
Published on 08/25/2026 at 17:45, 22 hours 17 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 22 hours 17 minutes ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
Published on 08/25/2026 at 08:30, 1 day 7 hours ago Eiffage wins several contracts worth a total of €132 million in the healthcare sector
Published on 08/24/2026 at 18:00, 1 day 22 hours ago Outstanding shares and voting rights statement at 31 July 2026
Published on 08/24/2026 at 17:59, 1 day 22 hours ago Saint-Gobain strengthens its positioning in construction chemicals and light construction in Latin America
